Preliminary clinical activity of repotrectinib (TPX-0005) in advanced ROS1 fusion-positive non-small cell lung cancer Meeting Abstract


Authors: Ou, S.; Cho, B. C.; Kim, D.; Drilon, A.; Lee, J.; Lin, J.; Zhu, V.; Ahn, M.; Camidge, D. R.; Shanna Stopatschinskaja, S.; Liu, J.; Cui, J.; Hyman, D.; Doebele, R.; Shaw, A.
Abstract Title: Preliminary clinical activity of repotrectinib (TPX-0005) in advanced ROS1 fusion-positive non-small cell lung cancer
Meeting Title: IASLC Asia Conference on Lung Cancer 2018
Keywords: mutation; resistance; ros1; g2032r
Journal Title: Journal of Thoracic Oncology
Volume: 13
Issue: 12 Suppl.
Meeting Dates: 2018 Nov 7-10
Meeting Location: Guangzhou, China
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2018-12-01
Start Page: S1047
Language: English
ACCESSION: WOS:000452742800010
PROVIDER: wos
DOI: 10.1016/j.jtho.2018.10.019
Notes: Meeting Abstract: OA09 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Hyman
    354 Hyman
  2. Alexander Edward Drilon
    632 Drilon